- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07951177
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion. (PED-MR)
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion: a Multicenter Randomized Study Versus Standard Treatment.
The goal of this clinical investigation is to evaluate the effectiveness of ETD + standard treatment versus standard treatment only, on the improvement of the tympanic membrane retraction, up to 18 months after intervention in children aged ]8-17[ with posterior mesotympanic retraction and middle ear effusion.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Fabian BLANC, Dr
- Telefonnummer: +33 0668248182
- E-post: fabian-blanc@chu-montpellier.fr
Studiesteder
-
-
-
Montpellier, Frankrike, 34000
- Fabian BLANC
-
Ta kontakt med:
- Fabian BLANC
- Telefonnummer: +33 0668248182
- E-post: fabian-blanc@chu-montpellier.fr
-
-
APHM
-
Marseille, APHM, Frankrike, 13005
- Richard NICOLLAS
-
Ta kontakt med:
- Richard NICOLLAS, PhD
- Telefonnummer: +33 0491386709
- E-post: richard.nicollas@ap-hm.fr
-
-
APHP Hôpital Necker
-
Paris, APHP Hôpital Necker, Frankrike, 75006
- François SIMON
-
Ta kontakt med:
- François SIMON, PhD
- Telefonnummer: +33 0153104600
- E-post: f.simon@aphp.fr
-
-
APHP Hôpital Robert Debre
-
Paris, APHP Hôpital Robert Debre, Frankrike, 75019
- Thiery VAN DEN ABBEELE
-
Ta kontakt med:
- Thiery VAN DEN ABBEELE, PhD
- Telefonnummer: +33 0140032179
- E-post: thierry.van-den-abbeele@aphp.fr
-
Underetterforsker:
- Natacha TEISSIER, PhD
-
Underetterforsker:
- Charlotte BENOIT, Dr
-
Underetterforsker:
- Emilie BOIS, Dr
-
-
HCL Hôptial Femme Mere Enfant
-
Lyon, HCL Hôptial Femme Mere Enfant, Frankrike, 69677
- Sonia AYARI
-
Ta kontakt med:
- Sonia AYARI, PhD
- Telefonnummer: +33 0427855729
- E-post: sonia.ayari-khalfallah@chu-lyon.fr
-
Underetterforsker:
- Aurélie COUDERT, Dr
-
Underetterforsker:
- Maxime TABEY, Dr
-
-
Hôpital Purpan
-
Toulouse, Hôpital Purpan, Frankrike, 40031
- Marie-Noël CALMELS
-
Ta kontakt med:
- Marie-Noël CALMES, PhD
- Telefonnummer: +33 0561779009
- E-post: calmels.mn@chu-toulouse.fr
-
Underetterforsker:
- Blandine BALADI
-
Underetterforsker:
- Yohan GALLOIS
-
-
Hôpital Salengro
-
Lille, Hôpital Salengro, Frankrike, 5900
- Philippine TOULEMONDE
-
Ta kontakt med:
- Philippine TOULEMONDE, Dr
- Telefonnummer: +33 0320446205
- E-post: philippine.toulemonde@chu-lille.fr
-
Underetterforsker:
- Hugo DELERRY
-
Underetterforsker:
- Christophe VINCENT
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Children aged strictly between 8 and 17 years of age
- Presenting a posterior mesotympanic retraction (grade II or III without adherence to the promontory from Sade's grade) with effusion
Exclusion Criteria:
- Weight strictly less than 20kg
- Down syndrome
- Craniosynostosis and other head and neck malformations
- History of skull base surgery
- History of skull fracture
- Failure to obtain consent
- Non-affiliation to a social security scheme
- Persons placed under legal protection
- Person participating in another research including a period of exclusion still in progress
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Eustachian tube dilation added to standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present. ETD involves using a transnasal balloon catheter, during general anesthesia, by the surgeon in charge of the patient. The device will be an Acclarent Aera 6x16 mm balloon, with a pressure set at 12 atm for 2 minutes in the eustachian tube. The manufacturer of the ETD device will organize a training session with hands-on on simulator, for all the principal investigators prior to the start of the study, to ensure homogenous intervention. |
Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical, coupled with the Acclarent Aera™ Eustachian Tube Balloon Dilation System. |
|
Aktiv komparator: Standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present, during general anesthesia, by the surgeon in charge of the patient. Tube placement will be in the anterior or inferior part of the tympanic membrane. Different design and brand of tympanostomy tube exist and are used in the different centers, leading to putative slightly different outcomes in term of adverse events related to the tympanostomy tube and duration. To decrease the cohort's heterogeneity, we propose to utilize the same tympanostomy tube for all the patients included in the study (Shepard's tympanostomy tube). |
Medical device: Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Tympanic membrane retraction
Tidsramme: Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
The assessment of tympanic membrane retraction is treated as a survival variable. Tympanic membrane retraction will be blindly assessed by an adjudication committee, through recorded otoendoscopy, based on the Sade's classification (in grade 0, I, II, III, IV, or V). The delay will be calculated as the time from intervention to improvement in tympanic membrane retraction (event), to loss of follow up (censoring), or to the study endpoint (censoring). |
Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mesotympanic retractation
Tidsramme: 6, 12 and 18 months
|
Mesotympanic retractation according to Sade's classification |
6, 12 and 18 months
|
|
Audiometry thresholds
Tidsramme: 6, 12 and 18 months
|
Mean of the air-bone gap at 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz |
6, 12 and 18 months
|
|
Tympanometry profile
Tidsramme: 6, 12 and 18 months
|
Tympanometry profile (A, B or C) |
6, 12 and 18 months
|
|
The quality of life
Tidsramme: 6, 12 and 18 months
|
Quality of Life measured through the OM-6 questionnaires |
6, 12 and 18 months
|
|
The quality of life
Tidsramme: 6, 12 and 18 months
|
Quality of Life measured through the PedsQL™ 4.0 questionnaires |
6, 12 and 18 months
|
|
Adverse events in both arms
Tidsramme: during the first week
|
Occurrence of adverse events and serious events during the first week, coded according to MedDRA. |
during the first week
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Fabian BLANC, Dr, University Hospital, Montpellier
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- RECHMPL26_0029
- 2026-A01144-47 (Annen identifikator: ID-RCB)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .